As U.S.-China Biotech Race Heats Up, Seattle Makes Its Case to D.C.

With the NSCEB’s recent visit to Seattle, local biotech leaders highlighted the need for stronger infrastructure and workforce development to keep biotechnology innovation in the U.S. Washington’s deep life sciences ecosystem is driving early innovation, but gaps in commercialization and manufacturing infrastructure continue to create challenges for companies moving research toward the market.